Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/24/26
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 03/24/26
Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallBenzinga • 03/23/26
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026GlobeNewsWire • 03/18/26
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer InstituteGlobeNewsWire • 03/04/26
Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 ReleaseZacks Investment Research • 03/02/26
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell TumorsGlobeNewsWire • 12/09/25
Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing LossGlobeNewsWire • 12/02/25
Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare ConferenceGlobeNewsWire • 11/26/25
Adherex Technologies Inc. (FENC) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/13/25
Adherex Technologies Inc. (FENC) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 10/30/25
Adherex Technologies Inc. (FENC) Reports Q2 Loss, Beats Revenue EstimatesZacks Investment Research • 08/14/25
Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business UpdateGlobeNewsWire • 08/14/25
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025GlobeNewsWire • 08/11/25
Recent Price Trend in Adherex Technologies (FENC) is Your Friend, Here's WhyZacks Investment Research • 07/15/25
Adherex Technologies Inc. (FENC) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/13/25